Literature DB >> 15332698

Community pharmacists' responses to drug-drug interaction alerts.

John E Murphy1, Ryan A Forrey, Usha Desiraju.   

Abstract

Mesh：

Year:  2004        PMID： 15332698     DOI： 10.1093/ajhp/61.14.1484

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  9 in total

1.  Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions.

Authors:  Kim R Saverno; Lisa E Hines; Terri L Warholak; Amy J Grizzle; Lauren Babits; Courtney Clark; Ann M Taylor; Daniel C Malone
Journal:  J Am Med Inform Assoc       Date:  2010-12-03       Impact factor: 4.497

2.  Management of potential drug interactions in community pharmacies: a questionnaire-based survey in Switzerland.

Authors:  Jörg Indermitte; Laura Erba; Marianne Beutler; Rudolf Bruppacher; Walter E Haefeli; Kurt E Hersberger
Journal:  Eur J Clin Pharmacol       Date:  2007-01-11       Impact factor: 2.953

3.  A drug interactions elective course.

Authors:  Jennifer Trujillo
Journal:  Am J Pharm Educ       Date:  2009-07-10       Impact factor: 2.047

4.  Clarity and applicability of drug-drug interaction management guidelines: a systematic appraisal by general practitioners and community pharmacists in the Netherlands.

Authors:  Annemieke Floor-Schreudering; Peter A G M De Smet; Henk Buurma; Sonia Amini; Marcel L Bouvy
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

5.  Comparison of a basic and an advanced pharmacotherapy-related clinical decision support system in a hospital care setting in the Netherlands.

Authors:  Willemijn L Eppenga; Hieronymus J Derijks; Jean M H Conemans; Walter A J J Hermens; Michel Wensing; Peter A G M De Smet
Journal:  J Am Med Inform Assoc       Date:  2011-09-02       Impact factor: 4.497

6.  Frequency of use of QT-interval prolonging drugs in psychiatry in Belgium.

Authors:  Eline Vandael; Thomas Marynissen; Johan Reyntens; Isabel Spriet; Joris Vandenberghe; Rik Willems; Veerle Foulon
Journal:  Int J Clin Pharm       Date:  2014-05-08

7.  Recommendations for selecting drug-drug interactions for clinical decision support.

Authors:  Hugh Tilson; Lisa E Hines; Gerald McEvoy; David M Weinstein; Philip D Hansten; Karl Matuszewski; Marianne le Comte; Stefanie Higby-Baker; Joseph T Hanlon; Lynn Pezzullo; Kathleen Vieson; Amy L Helwig; Shiew-Mei Huang; Anthony Perre; David W Bates; John Poikonen; Michael A Wittie; Amy J Grizzle; Mary Brown; Daniel C Malone
Journal:  Am J Health Syst Pharm       Date:  2016-04-15       Impact factor: 2.637

Review 8.  The evidence for the effectiveness of safety alerts in electronic patient medication record systems at the point of pharmacy order entry: a systematic review.

Authors:  Oluwagbemileke Ojeleye; Anthony Avery; Vaibhav Gupta; Matthew Boyd
Journal:  BMC Med Inform Decis Mak       Date:  2013-07-01       Impact factor: 2.796

9.  Management of drug interactions with beta-blockers: continuing education has a short-term impact.

Authors:  Annelies Driesen; Steven Simoens; Gert Laekeman
Journal:  Pharm Pract (Granada)       Date:  2006
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.